Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Shimadzu Establishes Latin American Subsidiary

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
Uruguayan subsidiary will strengthen company's sales and distribution whilst providing better support for customers and distributors in Central and South America.

Shimadzu Corporation established a wholly owned subsidiary Shimadzu Latin America S.A. (SLA) in Uruguay. 

Shimadzu Corporation established Shimadzu do Brasil Comercio Ltda. (SBL, located in Sao Paulo in Brazil) in 1997 and the company has mediated sales of Shimadzu products, provided services for them in Brazil, and provided instructions and support to distributors in each country in Central and South America. As Shimadzu's business expanded in Central and South America, the percentage of SBL's businesses within Brazil increased. Also, regulations in Brazil restricted the company's trading activities with other countries in Central and South America.

Uruguay is located between Brazil and Argentina. The capital Montevideo has good access to major cities in South America. It is 30 minutes to the Argentine capital Buenos Aires by air and two hours to Sao Paulo in Brazil where SBL is located by air. Moreover, Uruguay has some advantageous features. It has free trade zones where foreign-capital organizations can establish a company easily, companies can have bonded warehouses, and the degree of financial freedom is high as compared to surrounding countries. Since Uruguay's national language is Spanish, it will be easier for SLA to strengthen sales capabilities and support systems for customers and distributors in other Spanish-speaking countries in Central and South America, as compared to SBL located in Brazil, where national language is Portuguese.

After the establishment of SLA, SLA will become the parent company of SBL and its financial settlement will be consolidated with SBL so that SLA will be the base that reflects Shimadzu's business results in Central and South America.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Newly Identified Biochemical Pathway Could Be Target for Insulin Control
Researchers at Duke Medicine and the University of Alberta are reporting the identification of a new biochemical pathway to control insulin secretion from islet beta cells in the pancreas, establishing a potential target for insulin control.
Dirty,Crusty Meals Fit for (Long-Dormant) Microbes
Researchers apply the latest analytical techniques to further our understanding of desert biocrusts.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
Developing a Breathalyzer-Type Low Blood Sugar Warning Device For Diabetes
A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.
Identifying The 'Dimmer Switch' Of Diabetes
University of Alberta research gives new insight into what causes Type 2 diabetes.
10 to 1: Bugs Win in NASA study
Bugs are winning out, and that's a good thing according to NASA's Human Research Program.
MYC Oncogene Disrupts Cancers Rhythm
Findings inform time-dependent treatment for reducing side effects and increasing effectiveness of cancer medications.
Keeping Gut Bacteria in Balance Could Help Delay Age-related Diseases
A new study suggests that analyzing intestinal bacteria could be a promising way to predict health outcomes as we age.
Genome Mining Effort Discovers 19 New Natural Products in Four Years
Each of these products is a potential new drug. One of them has already been identified as an antibiotic.
New CRISPR-Cas9 Strategy Edits Genes Two Ways
A team of Harvard and MIT researchers have developed a way to perform genome engineering and gene regulation at the same time.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos